Mediaboss Marketing

DGAP-News: freenet AG / Key word(s): Quarter Results/Interim Report freenet AG increases revenue and result in third quarter

05.11.2013 / 18:00

=--------------------------------------------------------------------

- Group revenue rises by about 4 percent to 789.6 million euros (previous year: 756.5 million euros)

- Customer ownership increases by more than 3 percent to 8.67 million (previous year: 8.38 million)

- Group result increases by around 30 percent to 63.6 million euros (previous year: 49.0 million euros)

- Earnings per share rise to 1.40 euros in the first nine months (first nine months of 2012: 1.02 euros)

Bdelsdorf, 5 November 2013 - freenet AG today published its interim report for the third quarter of 2013 and confirmed its outlook for financial years 2013 and 2014.

In the third quarter, the company generated Group revenue of 789.6 million euros (previous year: 756.5 million euros). Unlike last year GRAVIS, Germany's leading digital lifestyle provider for Apple products, and MOTION TM, a leading online retailer in the mobile communications and telecommunications sector, contributed fully to the quarterly revenue figures. With revenue contribution of 781.6 million euros (previous year: 741.1 million euros) mobile communications remained the dominant business segment in the Group. Thus, the first nine months of the current financial year saw an increase in Group revenue to 2,374.5 million euros (first nine months 2012: 2,269.6 million euros).

'Customer ownership', a key performance indicator for high-value customer relationships in the freenet Group's mobile communications business, was increased by 0.287 million year-on-year to 8.67 million (previous year: 8.38 million). This increase was seen primarily (+0.184 million) in the no-frills sector, whose very price-conscious customers are mostly reached with discount brands through online sales channels. The especially valuable postpaid customer base also showed a positive year-on-year development, growing by 0.104 million.

Excerpt from:
PRESS RELEASE: freenet AG increases revenue and result in third quarter

DGAP-News: Symrise AG / Key word(s): Interim Report Symrise AG achieves Strong Growth in Sales and Earnings

05.11.2013 / 07:00

=--------------------------------------------------------------------

- Group sales increase by 10 % at local currency to EUR 1.4 billion

- Emerging Markets exceed Group growth with sales up by 11 % at local currency

- EBITDA increase of 10 % to EUR 290.2 million

- EBITDA margin increases to 20.7 %

Symrise AG continued its robust growth in the third quarter of 2013 with strong momentum. The Group increased sales to EUR 1,401.2 million in the first nine months of 2013; at local currency this translates into an increase of 10 %. Earnings before interest, taxes, depreciation and amortization (EBITDA) grew by 12 % at local currency to EUR 290.2 million. With an EBITDA margin of 20.7 %, Symrise remains one of the most profitable companies in the industry. Both divisions and every region contributed to this positive performance. In the Emerging Markets Symrise was able to increase sales by 11 % at local currency, thereby exceeding the Group's overall growth rate.

Dr. Heinz-Jrgen Bertram, CEO of Symrise AG said: 'Symrise has carried strong momentum into the second half of the year. We successfully left behind slight economic slowdowns, which occurred in certain markets. Along with high demand, our investments paid off: The new menthol capacities were well utilized and the US fragrance activities acquired at the beginning of the year provided an additional boost to our fragrance business. For the remaining weeks of 2013, we are confident on the continuation of Symrise's robust development. We plan to once again grow faster than the market and end the fiscal year as one of the most profitable companies in the industry.'

Double-Digit Growth in Nearly All Regions

The rest is here:
PRESS RELEASE: Symrise AG achieves Strong Growth in Sales and Earnings

DGAP-News: Reply Deutschland AG / Key word(s): Quarter Results Reply Deutschland AG: On Track, Positive Third Quarter

05.11.2013 / 09:13

=--------------------------------------------------------------------

Guidance confirmed

Gtersloh, 05 November 2013 - Reply Deutschland AG today published the 9 months results of financial year 2013. In the group, the software integrator achieved revenues of EUR 44.8 million, 4% above the previous year. Earnings before taxes, interest and depreciation (EBITDA) amounted to EUR 5.0 million following EUR 2.2 million in the last year. Earnings before taxes (EBT) were EUR 4.2 million coming from EUR 1.5 million in 2012. Altogether, Reply Deutschland group after tax and minority shares obtained a net profit of EUR 3.3 million until now (previous year: net profit EUR 0.7 million). The profitability situation has been influenced by one-off effects of the sale of Tool Reply (EUR 1.8 million pre-tax).

Third Quarter - Reply Deutschland AG Group achieved revenues of EUR 15.3 million in the third quarter of 2013, 4% more than those of the third quarter 2012. The EBITDA has increased to EUR 1.6 million, 40% more than in the third quarter 2012 (EUR 1.1 million). Amounting to 10.3% the EBITDA margin is back to the double-digit range (Q3 2012: EBITDA-margin 7.6%).

Liquidity and staff - Cash flow (according to DVFA/SG) up to now amounted to EUR 4.6 million (previous year: EUR 1.9 million) in 2013. Liquidity was EUR 12.8 million, subject to seasonal influences lower than the value achieved at the end of 2012 (EUR 15.3 million). The equity ratio rose to 58% following 55% at the end of 2012. 394 employees were active in the group at the end of September 2013, 2% less compared to the respective period of 2012.

Status and Outlook - Reply Deutschland AG group unchanged assumes to be able to continue the current development path with regard to growth and profitability. We therefore confirm the guidance for the year 2013 stating the revenue shall increase slightly. We as well work on the profitability which shall exceed the EBITDA margin of 6.2% obtained in 2012 on an annual basis.

For further inquiries please contact:

Michael Lckenktter Director Investor Relations Reply Bartholomusweg 26 33334 Gtersloh Tel.: +49 (5241) 5009-1017 E-Mail: m.lueckenkoetter@reply.de http://www.reply.de

Read more from the original source:
PRESS RELEASE: Reply Deutschland AG: On Track, Positive Third Quarter

DGAP-News: 4SC AG / Key word(s): Alliance/MiscellaneousPress Release: 4SC Discovery, AiCuris and CRELUX announce drugdiscovery collaboration04.11.2013 / 07:30---------------------------------------------------------------------Press ReleaseAiCuris, 4SC Discovery and CRELUX announce drug discovery collaborationAiCuris will use the high quality integrated drug discovery platform i2c ofCRELUX and 4SC Discovery to identify novel therapeutics for infectiousdiseasesPlanegg-Martinsried and Wuppertal, Germany, 4 November 2013 - 4SC AG(Frankfurt, Prime Standard: VSC), a discovery and development company oftargeted small molecule drugs mainly focusing on cancer and autoimmunediseases, today announced that 4SC Discovery GmbH, CRELUX GmbH and AiCurisGmbH & Co. KG have started a drug discovery collaboration to identify andvalidate novel small molecule compounds targeting pathogen-specificinteractions in infectious diseases. The collaboration is a further prooffor the innovative capacity and the high quality standard of the jointintegrated drug discovery platform i2c ('idea-to-candidate'), operated by4SC Discovery and CRELUX.Based on i2c, CRELUX and 4SC Discovery will discover and optimize smallmolecule compounds with the goal to deliver high quality drug candidatesfor a novel anti-infectious therapeutic approach by AiCuris. A virtualscreening approach using 4SC's proprietary 4SCan(R) method will beperformed to identify various inhibitors to the therapeutic target.Compounds identified as potential inhibitors of the respective target willbe verified by using both, established assays at AiCuris and the INTRACT invitro screening systems at CRELUX. In the course of the further discoveryprocess, protein structures of verified hits with the target will be solvedby i2c to enable rational design and guide the further chemicaloptimization.Prof. Helga Rbsamen-Schaeff, CEO of AiCuris comments: 'We are dedicated tofill our early pipeline with highly innovative next generation drugsagainst infectious diseases with high medical need and which are alsoactive against resistant pathogens. These may be derived from in houseresearch, from licensing or from collaborations.' Dr. Holger Zimmermann,Managing Director and Chief Scientific Officer at AiCuris adds: 'Based onour good experience in collaborating with 4SC we expect to identify soonfirst promising hits for further evaluation in our screening cascades. Thiscollaboration is an important contribution to our in house researchefforts and supports our goal to discover highly efficacious drugs whichhelp to solve major problems in treating infectious diseases.'Dr. Michael Schaeffer, Executive Director Strategy and Business of CRELUXGmbH, comments: 'This collaboration is a further proof of the value i2cbrings to its clients' drug discovery programmes. With Aicuris, we see aperfect fit of ideas, technologies and know-how and are especially pleasedto have gained yet another innovative and reknowned biotech company fromGermany as a partner. With this partnership, CRELUX and 4SC Discoverycontinue to build on their joint strategy to position themselves as premiumsolution providers to the global pharma and biotech industry covering thecomplete drug discovery value chain.'

See the original post:
DGAP-News: Press Release: 4SC Discovery, AiCuris and CRELUX announce drug discovery collaboration

DotComBar Review | Watch DotComBar Demo
download :http://tinyurl.com/lmf8d9c visit full:http://jvzoo-reviews.com/dotcombar-review/ DotComBar Review What is DotComBar ? DotComBar is a word press plugin that Instantly grabs the...

By: oh mark

Read the rest here:
DotComBar Review | Watch DotComBar Demo - Video